Neocardio Diagnostics LLP - healthcare in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
LLPIN AAS-4657 Incorporated 22 May 2020 ROC Chennai HQ Chennai, Tamil Nadu, India
Struck Off Limited Liability Partnership healthcare
Data last updated
Contribution obligation
₹1.75 Cr
As per LLP agreement
LLP age
6 yrs
Est. 2020
Designated partners
3
As per MCA filings
Brands
1
Associated brands
Last financials
Mar 2021
Balance sheet date
LLP status
Struck Off
MCA master data
Registrar
Chennai
ROC office
Incorporated
22 May 2020
Date of incorporation

About Neocardio Diagnostics LLP

Data last updated:

Neocardio Diagnostics LLP was a limited liability partnership (LLP) based in Chennai, Tamil Nadu, India. The LLP has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 22 May 2020.

The LLP was registered with the Registrar of Companies (ROC), Chennai, under LLPIN AAS-4657.

The LLP had a total obligation of contribution of β‚Ή1.75 Cr. It was led by designated partners including Karthik Anand Reddy and Sankaranarayanan Muthu Krishnan.

Its latest statement of accounts is for the year ended 31 March 2021. The registered office was at 3rd Floor Jhaver Plaza 1A Nungambakkam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034.

The LLP was associated with 1 brand: Apollo Hospitals.

Company Details of Neocardio Diagnostics LLP
LLPIN AAS-4657
Incorporation Date 22 May 2020
Total Obligation of Contribution β‚Ή1.75 Cr
ROC Chennai
Company Status Struck Off
Date of Last AGM 31 March 2021
Date of Balance Sheet 31 March 2021
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    3rd Floor Jhaver Plaza 1A Nungambakkam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034
  • Industry
    Healthcare, Medical & Laboratory Equipment
Comprehensive company report
Neocardio Diagnostics LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Unlock the full Neocardio Diagnostics LLP report

Financials, compliance, directors, charges, ownership and filings for Neocardio Diagnostics LLP in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Financials of Neocardio Diagnostics LLP FY 2021 filings available

Financial Statement Summary of Neocardio Diagnostics LLP

Statement of Account and SolvencyFY 2020-21
Income and Expenditure
Turnover••••
Other Income••••
Total Income••••
Purchases and Direct Costs••••
Personnel Expenses••••
Administrative Expenses••••
Interest••••
Depreciation••••
Total Expenses••••
Profit Before Tax••••
Tax••••
Profit After Tax••••
Profit Transferred to Partners••••
Assets and Liabilities
Partners' Contribution••••
Reserves and Surplus••••
Secured Loans••••
Unsecured Loans••••
Trade Payables••••
Other Liabilities and Provisions••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Loans and Advances••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Neocardio Diagnostics LLP

Statement of Account and SolvencyFY 2020-21
Profitability
Net Profit Margin••••
Return on Partners' Funds••••
Return on Assets••••
Liquidity and Debt
Current Ratio••••
Debt to Partners' Funds••••
Interest Coverage••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Turnover Growth••••
Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Neocardio Diagnostics are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Neocardio Diagnostics LLP

Neocardio Diagnostics has 3 designated partners on record. No former designated partners are listed.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Karthik Anand ReddyDesignated Partner22 May 20206 Years 4 MonthsAs last reported
Sankaranarayanan Muthu KrishnanDesignated Partner22 May 20206 Years 4 MonthsAs last reported
Adarsh JalanPartner22 May 20206 Years 4 MonthsAs last reported

Charges & Borrowings of Neocardio Diagnostics LLP

Neocardio Diagnostics LLP does not have any charges (loans) registered with the Registrar of Companies.

Associated Brands with Neocardio Diagnostics LLP

Neocardio Diagnostics operates one associated brand: Apollo Hospitals. Each brand links to its own profile.

BrandDescriptionWebsite
Chain of multispecialty hospitalsapollohospitals.com

Employees and EPFO Compliance at Neocardio Diagnostics LLP

Employment history and EPFO contributions of people linked to Neocardio Diagnostics.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Neocardio Diagnostics LLP

Neocardio Diagnostics LLP has 3 designated partner changes on record since 2020: 3 appointments. The latest: Adarsh Jalan was appointed as Partner on 22 May 2020.

AGM
Neocardio Diagnostics Llp last Annual general meeting of members was held on 31 Mar 2021 as per latest MCA records.
Filing
Neocardio Diagnostics Llp has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chennai.
Appointed
Adarsh Jalan was appointed as Partner.
Appointed
Karthik Anand Reddy was appointed as Designated Partner.
Appointed
Sankaranarayanan Muthu Krishnan was appointed as Designated Partner.
Incorporation
22 May 2020
Neocardio Diagnostics Llp was registered on 22 May 2020 with Roc Chennai & aged 6 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Neocardio Diagnostics LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Neocardio Diagnostics LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Neocardio Diagnostics LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Neocardio Diagnostics LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Neocardio Diagnostics LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neocardio Diagnostics LLP

Neocardio Diagnostics has a status of "Struck Off" as per MCA records. This means the LLP has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off LLP cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Neocardio Diagnostics was a limited liability partnership based in Chennai, Tamil Nadu, India. The LLP worked in medical and laboratory equipment, within the healthcare industry. It was incorporated on 22 May 2020 and is registered under LLPIN AAS-4657. The LLP has been struck off by the Registrar of Companies and is no longer operational.

Neocardio Diagnostics had 3 designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Neocardio Diagnostics is AAS-4657. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

The registered office of Neocardio Diagnostics is at 3rd Floor Jhaver Plaza 1A Nungambakkam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034.

Neocardio Diagnostics was incorporated on 22 May 2020. It is registered with the Registrar of Companies, Chennai.

The total obligation of contribution is β‚Ή1.75 Cr.

Neocardio Diagnostics operated in the healthcare industry, in the medical and laboratory equipment segment. It worked in this industry before it was struck off.

Adarsh Jalan was appointed as Partner on 22 May 2020. Karthik Anand Reddy was appointed as Designated Partner on 22 May 2020. Sankaranarayanan Muthu Krishnan was appointed as Designated Partner on 22 May 2020.

Neocardio Diagnostics has 1 associated brand: Apollo Hospitals.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available